Influenza A M2 Protein Inhibitor
36 drugs across 16 manufacturers|36 Generic,0 Brand
The Influenza A M2 Protein Inhibitor class contains 36 NDCs from 16 manufacturers (36 generic, 0 brand), at an average NADAC of $0.17 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
36
36G / 0B
Manufacturers
16
Avg $0.1728/unit
Avg 7d Change
-0.69%
Across 30 drugs with changes
7d Activity
of 36 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
16 manufacturers producing drugs in this therapeutic class(4 pricing outliers)
and 4 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Upsher-Smith Laboratories LLC manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Amantadine Hydrochloride market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Influenza A M2 Protein Inhibitor class?
The Influenza A M2 Protein Inhibitor class contains 36 NDCs from 16 manufacturers — 36 generic and 0 brand products.
What is the average price of Influenza A M2 Protein Inhibitor drugs?
The average NADAC for the Influenza A M2 Protein Inhibitor class is $0.1728 per unit across 36 NDCs.
Which manufacturers make Influenza A M2 Protein Inhibitor drugs?
16 manufacturers make drugs in the Influenza A M2 Protein Inhibitor class. Ranked by number of NDCs, the largest are Upsher-Smith Laboratories LLC (5), Strides Pharma Inc. (4), Major Pharmaceuticals (4), Alembic Pharmaceuticals Inc. (3), Advagen Pharma Ltd. (3).
How has Influenza A M2 Protein Inhibitor pricing changed recently?
Over the past 7 days, 9 NDCs in this class rose and 21 fell, with a class-wide average change of -0.7%.